Mannkind Corporation

This study tested whether adding an inhaled antibiotic called clofazimine to standard treatment could help people with a persistent lung infection caused by nontuberculous mycobacteria (NTM). The main goals were to see if the inhaled drug could clear the bacteria from the lungs a…